NAPSAGATRAN

CAS 159668-20-9 MFCD00932310

化学结构图

159668-20-9
SMILES: NC(=N)N1C[C@H](CNC(=O)C[C@H](NS(=O)(=O)C2=CC3C=CC=CC=3C=C2)C(=O)N(CC(O)=O)C2CC2)CCC1

化学属性

Mol. FormulaC26H34N6O6S
Mol. Weight558.657

别名和识别编码

Chemical NameNAPSAGATRAN
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Lundquist P, et al. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model. Drug Metab Dispos. 2014 Mar;42(3):459-68.
  • [3]. Himber J, et al. Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. J Thromb Haemost. 2003 May;1(5):889-95.
  • [1]. Pratico D, et al. Interaction of a thrombin inhibitor and a platelet GP IIb/IIIa antagonist in vivo: evidence thatthrombin mediates platelet aggregation and subsequent thromboxane A2 formation during coronary thrombolysis. J Pharmacol Exp Ther. 1997 Jun;281(3):1178-85.
  • [1]. Pratico D, et al. Interaction of a thrombin inhibitor and a platelet GP IIb/IIIa antagonist in vivo: evidence thatthrombin mediates platelet aggregation and subsequent thromboxane A2 formation during coronary thrombolysis. J Pharmacol Exp Ther. 1997 Jun;281(3):1178-85.
  • [2]. Lundquist P, et al. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflu

系列性分类

  1. Medical Research Areas
  2. Metabolism
  3. Thrombin  (凝血酶)

相关产品推荐